|
Real-time Estimate
Tradegate
18:20:17 25/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 60.62 EUR | +1.29% |
|
+4.40% | -4.65% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Chart: Technical Analysis
Stock exchange
BME
ROVI 60.55 €
+1.17%
5.14M
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
BME
| ROVI | 60.55EUR | +1.17% | 5.14M € | |
CBOE
| ROVIe | 60.62EUR | +1.04% | 630K € | |
Börse Stuttgart
| 41L | 60.55EUR | +1.09% | 60.55K € | |
Mexican S.E.
| ROVI N | 1,168.82MXN | -2.76% | 877K $ | |
OTC Markets
| LABFF | 67.17USD | +1.98% | 8.06K $ | |
Tradegate
| 41L | 60.60EUR | +1.08% | 7.09K € | |
Berne S.E.
| 41L | 52.24CHF | +0.85% | 313.44 CHF | |
Deutsche Boerse AG
| 41L | 59.95EUR | +1.10% | 0 € | |
CBOE
| 0ILL | 60.82EUR | 0.00% | 0 € | |
Boerse Muenchen
| 41L | 60.05EUR | +0.17% | 0 € | |
Wiener Boerse
| ROVI | 59.70EUR | +0.17% | 0 € | |
Borsa Italiana
| 1ROVI | 60.25EUR | +3.61% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Bearish |
| Resistance | 59.9 | 67.5 | 65.55 |
| Spread/Res. | +1.09% | -10.30% | -7.63% |
| Spread/Supp. | +6.41% | +12.86% | +11.82% |
| Support | 56.9 | 53.65 | 54.15 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ROVI Stock
- Charts Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions

















